Genomic & Biopharma News

Spark R&D chief High exits in wake of Roche takeover
Spark Therapeutics co-founder and R&D head Kathy High has left the gene therapy specialist in the wake of its takeover by Roche. The Basel-based Big Pharma talked up its ability to cope with the loss of the R&D chief, pointing to the 450-person team High helped build to back up its confidence.
Fierce Biotech, 2020-02-21 11:18:21

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
ORB Company News, 2016-12-28 18:58:47

Axion Announces Porsche Prize at Pittcon 2020
What do a Porsche and Axion have in common? The experience of a lifetime.
News Medical Life Sciences, 2020-02-21 11:17:00

Opdivo/Yervoy continues to impress in kidney cancer
The results represent the longest follow-up with any immuno-oncology–based therapy in previously untreated RCC patients.
PharmaTimes, 2020-02-21 11:12:17

GSK, Immatics team up for cancer cell therapies
Under the terms of the agreement, Immatics will receive an upfront payment of $45m.
PharmaTimes, 2020-02-21 11:04:41

NHS staff still face ‘unacceptable’ abuse from public
NHS leaders have confirmed that from April, NHS services will be able to protect staff by barring from non-emergency care any patient or visitor who inflicts discriminatory or harassing behaviour on staff.
PharmaTimes, 2020-02-21 10:58:12

Teva’s Austedo flunks in late-stage paediatric Tourette study
Compared to placebo, the drug didn’t achieve significant reduction in motor and phonic tics.
PharmaTimes, 2020-02-21 10:54:27

Using 'mini-brains' to detect harmful neurodevelopmental effects of antidepressant
Researchers at Johns Hopkins Bloomberg School of Public Health have demonstrated the use of stem-cell-derived "mini-brains" to detect harmful side effects of a common drug on the developing brain.
News Medical Life Sciences, 2020-02-21 09:26:09

Genfit's NASH key phase 3 data delayed
Genfit’s shares were in the red Friday morning after the French biotech announced it was delaying a data readout for its potential blockbuster fatty liver hopeful elafibranor.
Fierce Biotech, 2020-02-21 09:03:01

Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests.
ORB Company News, 2016-12-28 18:58:47

Isolating Single T-cells of Interest using an Optofluidic Platform
Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.
News Medical Life Sciences, 2020-02-21 08:35:13